title: Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.
abstract: Retinol binding protein 4 (RBP4) is a novel adipocyte-secreted protein that contributes to systemic insulin resistance. Experiments in mice suggest that elevated RBP4 causes insulin resistance. In the present study, we determined serum RBP4 concentration and evaluated its association with insulin resistance in women with polycystic ovarian syndrome (PCOS); 39 PCOS women and 45 healthy control subjects were enrolled in this study. Serum RBP4, fasting plasma glucose (FPG) and fasting serum insulin (FINS) were measured in all subjects. Furthermore, oral glucose tolerance test (OGTT), Botnia clamp (an intravenous glucose tolerance test followed by an euglycemic hyperinsulinemic clamp), and measurements of sex hormones were performed in 13 control subjects and all the PCOS women. The levels of serum RBP4 were elevated in PCOS women compared with the control (11.69 +/- 6.72 versus 7.75 +/- 5.96 microg/mL, p = 0.006). RBP4 levels were positively correlated with WHR (r = 0.216, p = 0.048), and intravenous glucose tolerance test beta cell index (IVGTT-beta index) which reflected beta cell function (r = 0.309, p = 0.028), but were inversely correlated with M value during Botnia clamp, which represented insulin sensitivity (r = -0.362, p = 0.008). No correlation was found between RBP4 and age, BMI, blood pressure, FPG, FINS, 2-h postprandial glucose, 2-h postprandial insulin, free testosterone, total testosterone, follicle-stimulating hormone (FSH), or luteinizing hormone (LH). In a linear stepwise regression analysis with a model including age, BMI, WHR, free testosterone, IVGTT-beta index, and M value as independent variables, only M value showed significant correlation with serum RBP4 levels (r2 = 0.105, f = 6.640, p = 0.012). In conclusion, serum RBP4 levels are significantly increased in PCOS women and associated with insulin resistance, which indicates that RBP4 may be a contributing factor linking adipose tissue with insulin resistance in PCOS.
authors.affiliation: Department of Endocrinology, First Affiliated Hospital, Chongqing Medical University, 1 Youyi Road, 400016, Chongqing, P. R. China.
authors.forename: Li
authors.initials: L
authors.lastname: Weiping
authors.forename: Cheng
authors.initials: C
authors.lastname: Qingfeng
authors.forename: Ma
authors.initials: M
authors.lastname: Shikun
authors.forename: Liu
authors.initials: L
authors.lastname: Xiurong
authors.forename: Qin
authors.initials: Q
authors.lastname: Hua
authors.forename: Bai
authors.initials: B
authors.lastname: Xiaoshu
authors.forename: Zhang
authors.initials: Z
authors.lastname: Suhua
authors.forename: Li
authors.initials: L
authors.lastname: Qifu
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D005260:Female; D005951:Glucose Tolerance Test / Q000379:methods; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D011085:Polycystic Ovary Syndrome / Q000378:metabolism*; D012044:Regression Analysis; D012177:Retinol-Binding Proteins / Q000378:metabolism*; D054839:Retinol-Binding Proteins, Plasma
chemical_list: C101326:RBP4 protein, human; D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma